PRCT
- PROCEPT BioRobotics Corporation
()
Overview
Company Summary
PROCEPT BioRobotics Corporation (PRCT) is a medical technology company that specializes in developing and commercializing innovative robotic systems for the minimally invasive treatment of various urological conditions.
The company's main focus is on developing a robotic surgical system known as the Aquablation� Therapy System. This system combines robotics, imaging, and waterjet technologies to perform targeted and precise removal of prostate tissue during the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH).
BPH is a common condition predominantly affecting elderly men, where the prostate gland enlarges and obstructs the normal flow of urine. Aquablation� Therapy offers a new approach to treating BPH, providing a minimally invasive alternative to traditional surgical techniques such as transurethral resection of the prostate (TURP). This technology enables surgeons to achieve a predictable and reproducible level of tissue removal while preserving the surrounding structures.
PROCEPT BioRobotics' Aquablation� Therapy System is designed to enhance surgical precision and reduce the risk of complications, such as sexual dysfunction or urinary incontinence. It utilizes real-time imaging to guide the robotic arm, which delivers a high-velocity waterjet to remove or ablate targeted tissue. The system's advanced technology allows for precise control and customization of the treatment for each patient.
By leveraging robotics and waterjet technology, PROCEPT BioRobotics aims to improve patient outcomes, minimize side effects, and enhance overall surgical efficiency. The company's goal is to offer a safe and effective alternative for patients with BPH, allowing them to regain normal urinary function and improve their quality of life.
In summary, PROCEPT BioRobotics Corporation develops and commercializes cutting-edge robotic systems and technologies, with a primary focus on Aquablation� Therapy for the minimally invasive treatment of BPH.